메뉴 건너뛰기




Volumn 8, Issue , 2010, Pages

Hypoxia-specific targets in cancer therapy: Role of splice variants

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; ANTINEOPLASTIC AGENT; HIF1A PROTEIN, HUMAN;

EID: 77955097923     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-8-45     Document Type: Note
Times cited : (13)

References (19)
  • 2
    • 68049105076 scopus 로고    scopus 로고
    • Role of hypoxia in the hallmarks of human cancer
    • 10.1002/jcb.22214, 19479945
    • Ruan K, Song G, Ouyang G. Role of hypoxia in the hallmarks of human cancer. J Cell Biochem 2009, 107:1053-1062. 10.1002/jcb.22214, 19479945.
    • (2009) J Cell Biochem , vol.107 , pp. 1053-1062
    • Ruan, K.1    Song, G.2    Ouyang, G.3
  • 4
    • 0036467638 scopus 로고    scopus 로고
    • Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer
    • 10.1200/JCO.20.3.680, 11821448
    • Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 2002, 20:680-687. 10.1200/JCO.20.3.680, 11821448.
    • (2002) J Clin Oncol , vol.20 , pp. 680-687
    • Fyles, A.1    Milosevic, M.2    Hedley, D.3    Pintilie, M.4    Levin, W.5    Manchul, L.6    Hill, R.P.7
  • 5
    • 34748860952 scopus 로고    scopus 로고
    • Hypoxic radiosensitization: adored and ignored
    • 10.1200/JCO.2007.12.7878, 17827455
    • Overgaard J. Hypoxic radiosensitization: adored and ignored. J Clin Oncol 2007, 25:4066-4074. 10.1200/JCO.2007.12.7878, 17827455.
    • (2007) J Clin Oncol , vol.25 , pp. 4066-4074
    • Overgaard, J.1
  • 6
    • 70350097618 scopus 로고    scopus 로고
    • Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia
    • Hoogsteen IJ, Lok J, Marres HA, Takes RP, Rijken PF, van der Kogel AJ, Kaanders JH. Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxia. Eur J Cancer 2009, 45:2904-2916.
    • (2009) Eur J Cancer , vol.45 , pp. 2904-2916
    • Hoogsteen, I.J.1    Lok, J.2    Marres, H.A.3    Takes, R.P.4    Rijken, P.F.5    van der Kogel, A.J.6    Kaanders, J.H.7
  • 7
    • 33646454133 scopus 로고    scopus 로고
    • Trans-Tasman Radiation Oncology Group Study 98.02. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02
    • 10.1200/JCO.2005.05.2878, 16648512
    • Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, Peters LJ. Trans-Tasman Radiation Oncology Group Study 98.02. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006, 24:2098-2104. 10.1200/JCO.2005.05.2878, 16648512.
    • (2006) J Clin Oncol , vol.24 , pp. 2098-2104
    • Rischin, D.1    Hicks, R.J.2    Fisher, R.3    Binns, D.4    Corry, J.5    Porceddu, S.6    Peters, L.J.7
  • 8
    • 26444467146 scopus 로고    scopus 로고
    • Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial
    • 10.1016/S1470-2045(05)70292-8, 16198981, Danish Head and Neck Cancer Study Group
    • Overgaard J, Eriksen JG, Nordsmark M, Alsner J, Horsman MR, . Danish Head and Neck Cancer Study Group Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol 2005, 6:757-764. 10.1016/S1470-2045(05)70292-8, 16198981, Danish Head and Neck Cancer Study Group.
    • (2005) Lancet Oncol , vol.6 , pp. 757-764
    • Overgaard, J.1    Eriksen, J.G.2    Nordsmark, M.3    Alsner, J.4    Horsman, M.R.5
  • 9
    • 35148828429 scopus 로고    scopus 로고
    • Hypoxia-inducible factor 1 (HIF-1) pathway
    • Semenza GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007, 407:cm8.
    • (2007) Sci STKE , vol.407
    • Semenza, G.L.1
  • 10
    • 39449090004 scopus 로고    scopus 로고
    • Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies
    • 10.2174/092986708783497391, 18288988
    • Bache M, Kappler M, Said HM, Staab A, Vordermark D. Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies. Curr Med Chem 2008, 15:322-338. 10.2174/092986708783497391, 18288988.
    • (2008) Curr Med Chem , vol.15 , pp. 322-338
    • Bache, M.1    Kappler, M.2    Said, H.M.3    Staab, A.4    Vordermark, D.5
  • 11
    • 33751277287 scopus 로고    scopus 로고
    • CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance
    • 10.1158/1078-0432.CCR-06-0480, 17085655
    • Brennan DJ, Jirstrom K, Kronblad A, Milikan RC, Landberg G, Duffy MJ, Ryden L, Gallagher WM, O'Brien SL. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res 2006, 12:6421-6431. 10.1158/1078-0432.CCR-06-0480, 17085655.
    • (2006) Clin Cancer Res , vol.12 , pp. 6421-6431
    • Brennan, D.J.1    Jirstrom, K.2    Kronblad, A.3    Milikan, R.C.4    Landberg, G.5    Duffy, M.J.6    Ryden, L.7    Gallagher, W.M.8    O'Brien, S.L.9
  • 12
    • 0037443587 scopus 로고    scopus 로고
    • Levels of hypoxia-inducible factor-1a independently predict prognosis in patients with lymph node negative breast carcinoma
    • 10.1002/cncr.11246, 12627523
    • Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ, van der Wall E. Levels of hypoxia-inducible factor-1a independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 2003, 97:1573-1581. 10.1002/cncr.11246, 12627523.
    • (2003) Cancer , vol.97 , pp. 1573-1581
    • Bos, R.1    van der Groep, P.2    Greijer, A.E.3    Shvarts, A.4    Meijer, S.5    Pinedo, H.M.6    Semenza, G.L.7    van Diest, P.J.8    van der Wall, E.9
  • 13
    • 0033405294 scopus 로고    scopus 로고
    • The hypoxic cell: a target for selective cancer therapy - eighteenth Bruce Cain Memorial Award lecture
    • Brown JM. The hypoxic cell: a target for selective cancer therapy - eighteenth Bruce Cain Memorial Award lecture. Cancer Res 1999, 59:5863-5870.
    • (1999) Cancer Res , vol.59 , pp. 5863-5870
    • Brown, J.M.1
  • 14
    • 70349673606 scopus 로고    scopus 로고
    • Inhibiting the hypoxia response for cancer therapy: the new kid on the block
    • 10.1158/1078-0432.CCR-09-1650, 19789327
    • Koh MY, Spivak-Kroizman TR, Powis G. Inhibiting the hypoxia response for cancer therapy: the new kid on the block. Clin Cancer Res 2009, 15:5945-5946. 10.1158/1078-0432.CCR-09-1650, 19789327.
    • (2009) Clin Cancer Res , vol.15 , pp. 5945-5946
    • Koh, M.Y.1    Spivak-Kroizman, T.R.2    Powis, G.3
  • 15
    • 33847023140 scopus 로고    scopus 로고
    • Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting
    • 10.1158/0008-5472.CAN-06-4744, 17283112
    • Dewhirst MW. Intermittent hypoxia furthers the rationale for hypoxia-inducible factor-1 targeting. Cancer Res 2007, 67:854-855. 10.1158/0008-5472.CAN-06-4744, 17283112.
    • (2007) Cancer Res , vol.67 , pp. 854-855
    • Dewhirst, M.W.1
  • 19
    • 36148961902 scopus 로고    scopus 로고
    • The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in soft-tissue sarcoma cells in vitro under different oxygen conditions
    • 10.1038/sj.cgt.7701090, 17885676
    • Kappler M, Rot S, Taubert H, Greither T, Bartel F, Dellas K, Hänsgen G, Trott KR, Bache M. The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in soft-tissue sarcoma cells in vitro under different oxygen conditions. Cancer Gene Ther 2007, 14:994-1001. 10.1038/sj.cgt.7701090, 17885676.
    • (2007) Cancer Gene Ther , vol.14 , pp. 994-1001
    • Kappler, M.1    Rot, S.2    Taubert, H.3    Greither, T.4    Bartel, F.5    Dellas, K.6    Hänsgen, G.7    Trott, K.R.8    Bache, M.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.